Alert: New Earnings Report (3/26/24)-Catalyst Biosciences Inc (NASDAQ: CBIO).
Catalyst Biosciences Inc (NASDAQ: CBIO) has reported E.P.S. of $-1.41 for its fourth fiscal quarter (ending December 31) versus $-1.27 for the same period a year ago. E.P.S. were $-1.41 for the latest four quarters […]